70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

References

Page 1

	Year	Citations
Gene expression profiling predicts clinical outcome of breast cancer Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver, Nature Systems BiologyEngineeringBreast OncologyMedicineCancer Genomics	2002	9.5K
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer Joseph A. Sparano, Robert J. Gray, Della Makower, New England Journal of Medicine	2018	2.3K
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer Fátima Cardoso, Laura J. van’t Veer, Jan Bogaerts, New England Journal of Medicine	2016	2K
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Alan S. Coates, Eric P. Winer, Aron Goldhirsch, Annals of Oncology	2015	1.8K
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 Aron Goldhirsch, James N. Ingle, Richard D. Gelber, Annals of Oncology	2009	1.4K
Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast Cancer Peter M. Ravdin, Laura A. Siminoff, Greg Davis, Journal of Clinical Oncology	2001	1K
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer Prudence A. Francis, Olivia Pagani, Gini F. Fleming, New England Journal of Medicine	2018	646
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin, New England Journal of Medicine	2019	532
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update Ian E. Krop, Nofisat Ismaila, Fabrice André, Journal of Clinical Oncology Prognostic BiomarkersNode-negative Breast CancerBreast OncologyMedicineCancer Management	2017	312
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study Stella Mook, Marjanka K. Schmidt, Giuseppe Viale, Breast Cancer Research and Treatment 70-Gene Prognosis-signature PredictsPrognostic EvaluationPrognostic BiomarkersBreast OncologyCancer Epidemiology	2008	296

Page 1